TrialX provides cutting-edge information on new medical treatments and clinical trials in your area.
Meet Dory , your personalized virtual assistant to find clinical trials. Go head, ask her anything. x
All > Massachusetts Investigators

Geoffrey I. Shapiro, M.D., Ph.D.

Dana Farber Cancer Institute (DFCI)


Boston, Massachusetts - 02115 (617-632-6623)

Dana-Farber Cancer Institute


Boston, Massachusetts - 02115

Dana Farber /Harvard Cancer Center


Boston, Massachusetts - 02115 (617-632-3237)

Dana-Farber Cancer Center


Boston, Massachusetts - 01890 (617-632-4391)
  • CLINICAL TRIALS 4
  • CONDITIONS2
  • INTERVENTIONS5
  • SINCE2007
A Study of Intravenous XMT-1107 in Patients With Advanced Solid Tumors

March 2010 - October 2011
A Study of Oral Sapacitabine and Oral Seliciclib in Patients With Advanced Solid Tumors

February 2009 - August 2010
Study of the Safety and Pharmacokinetics of XL147 in Adults With Solid Tumors or Lymphoma

June 2007 - March 2011
Study of XL184 in Adults With Advanced Malignancies

August 2009 - July 2011
Lymphoma

Neoplasms

Placebo

Xl184

Xl147

Xmt-1107

Sapacitabine And Seliciclib

Related Investigators

Massimo Loda, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

Suzanne Shusterman

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Childrens Hospital Boston, Dana-Farber Cancer Institute. Children's Hospital Boston

Patrick Y. Wen, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute Dana Farber / Brigham and Women's Cancer Center Dana-Farber Cancer Institute, Center for Neuro-Oncology Dana-Farber Cancer Instiute

Lewis B. Silverman, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute and Children's Hospital Dana Faber Cancer Institute, Children's Hospital, Dept. of Pediatric Oncology Children's Hospital Boston Dana-Farber Cancer Institute

Kay Kehoe, Coordinator

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

Jennifer Brown, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute

Rachel A. Freedman

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

Edwin P. Alyea, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute

F. Stephen Hodi, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute Dana-Farber Cancer Center

Beth A. Overmoyer, MD, FACP

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

©2012 Applied Informatics, Inc.
As Seen On:
  • New York Times
  • USA Today
  • bio-itworld logo